chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lacrimation increased, Muscle tightness, Myalgia, Nausea
Clinical narrative: Nausea; Diarrhea; vaccination site redness/swelling; Muscle aches; Pain; Jaw tightness; Eye pain; Sinus pain; Congestion; Chest tightness; runny eyes; tight shoulder/neck; Fever; injection site redness/swelling,; jaw tightness and pain; Headache; Dizziness; Tremors; This is a spontaneous report received from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 14March2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, overweight and penicillin allergy eliminated in 2019. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), desloratadine (MANUFACTURER UNKNOWN), all for unknown indication from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 21Feb2021 at 17:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 15Mar2021 at 02:30, 12 hours post through 36 hours post, the patient experienced severe headache, dizziness, tremors, surges felt head to toe or vibrations and fever for 2 hours up to 102-102.8. On 15Mar2021 at 18:15, 28 hours post dose, the patient experienced nausea, diarrhea, injection site redness/swelling, pain and muscle aches, jaw tightness and pain, eye pain, sinus pain, congestion, dizziness, chest tightness, runny eyes and tight shoulder or neck. The patient received treatment for the adverse events and was treated with acetaminophen (MANUFACTURER UNKNOWN). The clinical outcome of the event fever was recovered on 15Mar2021 and headache, dizziness, tremor, nausea, diarrhea, vaccination site swelling, vaccination site erythema, pain, muscle aches, jaw tightness, jaw pain, eye pain, sinus pain, sinus congestion, chest tightness, watery eyes, neck tightness was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in jaw, Pyrexia, Sinus congestion, Sinus pain
Clinical narrative: Nausea; Diarrhea; vaccination site redness/swelling; Muscle aches; Pain; Jaw tightness; Eye pain; Sinus pain; Congestion; Chest tightness; runny eyes; tight shoulder/neck; Fever; injection site redness/swelling,; jaw tightness and pain; Headache; Dizziness; Tremors; This is a spontaneous report received from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 14March2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, overweight and penicillin allergy eliminated in 2019. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), desloratadine (MANUFACTURER UNKNOWN), all for unknown indication from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 21Feb2021 at 17:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 15Mar2021 at 02:30, 12 hours post through 36 hours post, the patient experienced severe headache, dizziness, tremors, surges felt head to toe or vibrations and fever for 2 hours up to 102-102.8. On 15Mar2021 at 18:15, 28 hours post dose, the patient experienced nausea, diarrhea, injection site redness/swelling, pain and muscle aches, jaw tightness and pain, eye pain, sinus pain, congestion, dizziness, chest tightness, runny eyes and tight shoulder or neck. The patient received treatment for the adverse events and was treated with acetaminophen (MANUFACTURER UNKNOWN). The clinical outcome of the event fever was recovered on 15Mar2021 and headache, dizziness, tremor, nausea, diarrhea, vaccination site swelling, vaccination site erythema, pain, muscle aches, jaw tightness, jaw pain, eye pain, sinus pain, sinus congestion, chest tightness, watery eyes, neck tightness was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Nausea; Diarrhea; vaccination site redness/swelling; Muscle aches; Pain; Jaw tightness; Eye pain; Sinus pain; Congestion; Chest tightness; runny eyes; tight shoulder/neck; Fever; injection site redness/swelling,; jaw tightness and pain; Headache; Dizziness; Tremors; This is a spontaneous report received from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 14March2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, overweight and penicillin allergy eliminated in 2019. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), desloratadine (MANUFACTURER UNKNOWN), all for unknown indication from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 21Feb2021 at 17:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 15Mar2021 at 02:30, 12 hours post through 36 hours post, the patient experienced severe headache, dizziness, tremors, surges felt head to toe or vibrations and fever for 2 hours up to 102-102.8. On 15Mar2021 at 18:15, 28 hours post dose, the patient experienced nausea, diarrhea, injection site redness/swelling, pain and muscle aches, jaw tightness and pain, eye pain, sinus pain, congestion, dizziness, chest tightness, runny eyes and tight shoulder or neck. The patient received treatment for the adverse events and was treated with acetaminophen (MANUFACTURER UNKNOWN). The clinical outcome of the event fever was recovered on 15Mar2021 and headache, dizziness, tremor, nausea, diarrhea, vaccination site swelling, vaccination site erythema, pain, muscle aches, jaw tightness, jaw pain, eye pain, sinus pain, sinus congestion, chest tightness, watery eyes, neck tightness was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling hot, Flushing, Nausea, Oedema peripheral
Clinical narrative: feeling like legs were made of jello.; Very hot; flushed face; weak; Merely nauseated; This is a spontaneous report from a contactable consumer, the patient.  A 60-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 05Mar2021 at 12:45 (at the age of 60-years-old), as a single dose for COVID-19 immunisation.  The patient's medical history included hashimoto's thyroiditis. Patient had allergies to penicillin. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN) for an unknown indication.  On 05Mar2021 at 13:30, patient experienced very hot, flushed face and weak and feeling like legs were made of jello. This lasted for approximately 3 hours. On 05Mar2021, patient experienced merely nauseated. On 17Mar2021, patient underwent lab tests nasal swab (PCR) and result was negative. No therapeutic measures were taken for the reported events. The clinical outcome of the events very hot, flushed face and weak, feeling like legs were made of jello and merely nauseated was recovered/ resolved on 05Mar2021.    No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Polymerase chain reaction
Clinical narrative: feeling like legs were made of jello.; Very hot; flushed face; weak; Merely nauseated; This is a spontaneous report from a contactable consumer, the patient.  A 60-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 05Mar2021 at 12:45 (at the age of 60-years-old), as a single dose for COVID-19 immunisation.  The patient's medical history included hashimoto's thyroiditis. Patient had allergies to penicillin. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN) for an unknown indication.  On 05Mar2021 at 13:30, patient experienced very hot, flushed face and weak and feeling like legs were made of jello. This lasted for approximately 3 hours. On 05Mar2021, patient experienced merely nauseated. On 17Mar2021, patient underwent lab tests nasal swab (PCR) and result was negative. No therapeutic measures were taken for the reported events. The clinical outcome of the events very hot, flushed face and weak, feeling like legs were made of jello and merely nauseated was recovered/ resolved on 05Mar2021.    No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This is a spontaneous report from a contactable consumer (patient)  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on an unspecified date as single dose for covid-19 immunisation  .  The patient medical history and concomitant medications were not reported. Patient got her first dose of the vaccine and experienced side effects after getting it, she said she had hives on an unspecified date. The outcome of the event was unknown. Patient asked if it was safe for her to get the second dose of the vaccine. No follow-up attempts are possible, information about batch number cannot be obtained
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Flushing, Heart rate increased, Parosmia
Clinical narrative: Metallic smell/taste; Metallic smell; Elevated heartrate; Flushed; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration at left arm on 16Mar2021 at 13:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included hypertension, ADHD , anxiety/depression and also had allergy to contrast dye. Concomitant medications included losartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN); all for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient didn't receive any other vaccine within 4 weeks prior to COVID-19 vaccine. On 16Mar2021 at 13:30, the patient experienced metallic smell, metallic taste, elevated heart rate, flushed and tiredness. No therapeutic measures were taken for the events. The clinical outcome of metallic smell, metallic taste, elevated heart rate, flushed and tiredness was resolved on an unknown date at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Bilateral muscular (?) neck pain, most pronounced when I move my head or neck.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received first dose of BNT16B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), solution for injection, via an unspecified route of administration in the left arm on 17Mar2021 at 11:00 AM (at the age 69-year-old) as first single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to any medication, food or other products. Concomitant medication included vit D3 (MANUFACTURER UNKNOWN), cranberry caps (MANUFACTURER UNKNOWN), vit C (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN), benad (MANUFACTURER UNKNOWN); all for an unknown indication from unknown dates, unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, at 11:30, the patient experienced bilateral muscular neck pain, most pronounced when the head or neck was moved. The patient did not receive any treatment for the event. The clinical outcome of bilateral muscular neck pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site pain
Clinical narrative: soreness in the armpits area; experienced soreness at the injection site; This is a spontaneous report from a contactable consumer (patient) A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) via an unspecified route of administration on an unspecified date in Mar2021 as single dose for covid-19 immunisation.The patient medical history and concomitant medications were not reported.  The patient experienced soreness at the injection site in Mar2021 and on 18Mar2021 had soreness in the armpits area. Patient wanted to know if they suggest taking Tylenol for it and wanted to know what area blood clot will show up.The outcome of the events was unknown.No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Swollen throat within 1 hour; This is a spontaneous report from a contactable consumer, the patient. A 69-years-old non-pregnant female patient received first dose of BNT162B2((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 17March2021at 23:15 (at the age of 69-years old) as a single dose for COVID-19 Immunization. Medical history included diabetes and heart condition, fruits allergy (walnuts, citrus), food allergy (gluten, tomatoes). Past drug history included allergy to aspirin, penicillin and norco. Concomitant medications included coreg (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), calcium supplement, (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN) for unknown indication. Patient did not receive any other vaccine within 4 weeks prior to the COVID-19 and was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17March2021 patient experienced swollen throat within 1 hour of vaccination. Benadryl tablets were taken on an unknown date for the event. The clinical outcome of the event swollen throat was recovered. No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer. A 47-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EP7534) via unspecified route of administration in the left arm on 17Mar2021 at 01:00 pm (at the age of 47-years-old) as a single dose for Covid-19 immunisation. The patients medical history was not reported. Concomitant medication was reported are Zyrtec (MANUFACTURER UNKNOWN), Wellbutrin (MANUFACTURER UNKNOWN), Magnesium (MANUFACTURER UNKNOWN), Turmeric (MANUFACTURER UNKNOWN), Biotin (MANUFACTURER UNKNOWN) which are taken within two weeks of vaccination. Patient was allergic to macrolides. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. On 17Mar2021, patient experienced headache. The clinical outcome of headache was reported as recovered.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Polymerase chain reaction
Clinical narrative: lethargy; Tiredness; This is a spontaneous report from a non-contactable consumer. A 36-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: UNKNOWN) via an unspecified route of administration on left arm on 12Mar2021 at 12:00 (age at the time of vaccination was 37 years-old) as a single first dose for COVID-19 immunisation. The patient had not had any other vaccines within four weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent a lab test on 02Dec2020 which included nasal swab PCR test for COVID-19 and the test result was negative. On 13Mar2021 at 12:00 the patient experienced events tenderness and lethargy. Therapeutic measures for the reported events were not taken. The clinical outcome of tenderness and lethargy was recovered at the time of report. Vaccine Facility information available.   No further information is expected. Information about lot number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Lymphadenopathy
Clinical narrative: Sleeplessness; Swelling of lymph glands; Feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 09Mar2021 at 17:15, as a single dose for COVID-19 immunisation. The patient's medical history included degenerative joint disease, mild hearing loss, asthma, depression, anxiety, seasonal allergies, migraines and vertigo. The patient had no history of allergies to food, medications or any other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included ZOLOFT, joint support (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN), VIT D (MANUFACTURER UNKNOWN), ZYRTEC and probi (MANUFACTURER UNKNOWN), all for unknown indications received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021 at 16:00, the patient experienced sleeplessness (9 days so far), swelling of lymph glands which lasted for 3 days and feeling tired for 4 days. The patient did not receive any treatment for the reported events. The clinical outcome of the events sleeplessness was resolving; swollen lymph glands was resolved on 13Mar2021 and feeling tired was resolved on 14Mar2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Vomiting; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown), via unspecified route of administration on the left arm on 17March2021 at 11:00 hours as a single dose for COVID-19 immunisation. Medical history included ptds, anxiety disorder, hashimotos thyroiditis, sleep apnea and pcos. Concomitant medications included metformine (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), levo (MANUFACTURER UNKNOWN), prazosin (MANUFACTURER UNKNOWN), hydroxyzine (MANUFACTURER UNKNOWN). The patient had allergies to nuts. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18March2021 at 07:00 hours, the patient experienced vomiting and diarrhea. The patient did not receive any treatment for the adverse events. The clinical outcome of the events vomiting and diarrhea was recovering.    Information about lot number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain, Pyrexia, SARS-CoV-2 test, Vertigo
Clinical narrative: Fever; body aches; vertigo; Dizziness; This is a spontaneous report received from a contactable patient. A 25-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 02:00 PM (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient did not have allergies to medications, food, or other products. Medical history included asthma. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN), Ibuprofen (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN). Prior to the vaccination the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Mar2021, the patient had PCR saliva test and the result was negative. On 17Mar2021, the patient experienced body aches, dizziness, fever and vertigo. The clinical outcome of body aches, dizziness, fever and vertigo was unknown at the time of report. No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Malaise, Muscle spasms, Nausea
Clinical narrative: dizziness; Nausea; Not feeling well; Left arm pain; fever; Chills; Facial swelling; pain to neck; Muscle spasm in face (lips); This is a spontaneous report from a contactable consumer, the patient. A 23-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6207) via an unspecified route of administration in the left arm on 13Mar2021 at 14:00 (at the age of  23-years-old) as a first dose for COVID-19 immunisation. The patients medical history included diabetic, arthritis, fibromyalgia, High blood pressure, neuropathy and Gastrointestinal (GI) problems. Patient was allergic to Benadryl and certain anaesthesia. Concomitant medication taken within two weeks included ADVIL, HUMALOG, aspirin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), FURMIDE, gaba (MANUFACTURER UNKNOWN) all taken for unknown indications from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 13Mar2021, at 14:30 the patient developed dizziness, immediately after dizziness patient had nausea, the patient was not feeling well and had left arm pain, fever, chills, facial swelling and pain to neck and muscle spasms in face (lip). The facility where the vaccine was administered was reported to be other. No therapeutic measures were taken for these adverse events. The outcome of the events dizziness, nausea, was not feeling well, left arm pain, fever, chills, facial swelling, pain to neck and muscle spasms in face (lip) was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Pyrexia, Swelling face
Clinical narrative: dizziness; Nausea; Not feeling well; Left arm pain; fever; Chills; Facial swelling; pain to neck; Muscle spasm in face (lips); This is a spontaneous report from a contactable consumer, the patient. A 23-years-old non- pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6207) via an unspecified route of administration in the left arm on 13Mar2021 at 14:00 (at the age of  23-years-old) as a first dose for COVID-19 immunisation. The patients medical history included diabetic, arthritis, fibromyalgia, High blood pressure, neuropathy and Gastrointestinal (GI) problems. Patient was allergic to Benadryl and certain anaesthesia. Concomitant medication taken within two weeks included ADVIL, HUMALOG, aspirin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), FURMIDE, gaba (MANUFACTURER UNKNOWN) all taken for unknown indications from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 13Mar2021, at 14:30 the patient developed dizziness, immediately after dizziness patient had nausea, the patient was not feeling well and had left arm pain, fever, chills, facial swelling and pain to neck and muscle spasms in face (lip). The facility where the vaccine was administered was reported to be other. No therapeutic measures were taken for these adverse events. The outcome of the events dizziness, nausea, was not feeling well, left arm pain, fever, chills, facial swelling, pain to neck and muscle spasms in face (lip) was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EL3247), via an unspecified route of administration in right arm on 02Feb2021 at 00:00 (at the age of 77-years-old), and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6200), via an unspecified route of administration in right arm on 25Feb2021 as a single dose for COVID-19 immunisation. The patient's medical history included IBS, diabetes insipidus, gastroesophageal reflux disease (GERD), osteoarthritis, hypertension and high cholesterol on an unknown date. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications within two weeks of vaccination. On 02Feb2021, the patient experienced diarrhea lasting from first dose to current date 18Mar2021 which was uncontrolled by budesmide. The patient had undergone treatment with budesmide for diarrhea. The outcome of the event diarrhea was not recovered at the time of reporting and had resulted in Doctor or other healthcare professional office/clinic visit.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: generalized pruritus; This is a spontaneous report from a contactable other healthcare professional. A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6206), via an unspecified route of administration on his left arm on 08Mar2021 at 02:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient was allergic to latex. Prior to vaccination patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and also within 2 weeks of vaccination. On 15Mar2021 the patient experienced generalized pruritus. The clinical outcome of generalized pruritus was not recovered. No treatment was received for the adverse event.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: headache; joint aches; This is a spontaneous report from a contactable non healthcare professional, the patient. A 67-year-old non-pregnant female patient received the unknown dose of BNT162be (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EL9264) via an unspecified route of administration in the left arm on 11Feb2021 at 10:15 A.M. (at the age of 67-year-old) as a single dose for COVID-19 vaccination. Patient Medical history not reported. Patient was allergic to molds, diesels products and bees. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patients concomitant medications included alegra, nexium, probiotic and scripts, all for unknown indications from unknown dates and unknown if ongoing. vaccine was administered in a hospital. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 11Feb2021, at 7:30 P.M. patient experienced minor tolerable headache and joint aches. The patient did not receive any treatment for the events headache and joint ache. The clinical outcome of headache and joint ache was resolved. No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia, Sunburn
Clinical narrative: Face red; Little tingly in  face; Sun burn; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955), via an unspecified route of administration in left arm on 17Mar2021 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not tested for COVID-19. The patient medical history included allergy to dye used for CAT scans. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included TheraCal D 200 supplement for an unknown indication from an unspecified date and unknown if ongoing. On 17Mar2021, after about 15 minutes of vaccination, the patient face became red and felt a little tingly and a little like a sun burn. No itchiness or hives developed anywhere on her body. After about 45 minutes she decided to take one dose of Benadryl. The clinical outcomes of face red, tingly and sunburn was recovered/ resolved.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: developed a fever last night; This is a spontaneous report from a contactable consumer (patient) A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) via an unspecified route of administration on 04Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient did not experience side effects until 10 days later (as reported) and developed a fever last night (on 17Mar2021) but felt fine as of 18Mar2021. The final outcome of the event fever was reported as recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response increased
Clinical narrative: Elevated Immune System Response; This is a spontaneous report received from a contactable consumer, the patient. A 68-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration, in the left arm on 17Mar2021 at 10:00 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported and did not have allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not test positive for COVID-19. Concomitant medication included levothyroxine sodium (SYNTHROID) 125 mg from unknown dates for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 02:00, the patient experienced elevated immune system response. The patient did not receive any treatment for the event elevated immune system response. The clinical outcome of the event elevated immune system response (therapeutic response increased) was not resolved.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Extremely exhausted; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- EN6207) via an unspecified route of administration in left arm on 16Mar2021 at 13:00 as single dose for COVID-19 vaccination. Medical history included Glaucoma from an unknown start date and was continuing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other  vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Eye drops generic name unknown (MANUFACTURER UNKNOWN ) for glaucoma since an unknown start date and unknown if ongoing. Allergies to medications, food, or other products were all none. On 17Mar2021 at 09:00, the patient experienced soreness in arm and was extremely exhausted. No treatment was received for the events. The clinical outcome of soreness in arm and extremely exhausted were recovering.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 23Feb2021 08:30 (at 33-year-old, not pregnant at the time of vaccination) as 1st dose, single dose for COVID-19 immunisation. Medical history included HPV infection. No known allergies. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced mild pain at injection site 5 days (1st dose) on 2021. The outcome of the event was recovered on an unspecified date in 2021. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Skin warm
Clinical narrative: Arm hot; Arm hurts to move it.; Headache; Exhausted like I have not slept; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 38-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6198) via an unspecified route of administration in the left arm on 16Mar2021 at 15:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy (unspecified whether for medications or food or other products). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patients past drug history included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6200), via an unspecified route of administration in the left arm on 23Feb201 at 14:30, for COVID-19 immunisation. On 17Mar2021 at 02:30, the patient experienced arm hot, arms hurt to move it, headache and exhausted like I have not slept. The clinical outcome of the events arms hot, arms hurt to move, headache and exhausted like patient had not slept was recovering. No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Polymerase chain reaction
Clinical narrative: significant fatigue; This is a spontaneous report from a contactable patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 02Mar2021 at 11:45AM (at the age of 45 years old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient not received any other vaccines within 4 weeks prior to covid vaccine and did not received any other medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient not had allergies to medications, food, or other products. On 07Mar2021, the patient had nasal swab (PCR) test the result was negative. On 11Mar2021, the patient experienced significant fatigue. The clinical outcome of significant fatigue was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen and tender lymph nodes under left armpit that appeared after the 2nd day and has continued so far in to day 4; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 10:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient did not have any allergies to food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications include LEXA PRO 10 mg and wellbutrin 300mg (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN) from an unknown date. Previously patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 22Feb2021 at 12:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine with four weeks prior to the COVID-19 vaccine. On 17Mar2021, the patient experienced swollen and tender lymph nodes under left armpit that appeared after the 2nd day and had continued so far in day 4. Patient did not receive any treatment for the swollen lymph nodes. The clinical outcome of swollen and tender lymph nodes was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Pain
Clinical narrative: Body ache; Warm Head; This is a spontaneous report received from a contactable consumer, the patient. A 63-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the right arm on 17Mar2021 at 12:00 PM (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes and liver cancer. Concomitant medications included ozempic (MANUFACTURER UNKNOWN), jardiance pravastatin (MANUFACTURER UNKNOWN) and turmeric (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the right arm on 23Feb2021 at 14:00 PM (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient had no symptoms associated with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not have any allergies to medications, food, or other products. On 17Mar2021, patient experienced warm head and body ache. The patient did not receive any treatment for the adverse events. The clinical outcome of the events warm head and body ache was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Headache, Injection site swelling, Pain in extremity
Clinical narrative: Diarrhea; Upset stomach; Left arm pain; Red bump at injection site; Headache; This is a spontaneous report from a contactable non-Healthcare professional , the Patient. A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: not known) via unspecified route of administration in the left arm on 14Mar2021 at 08:30 am (at the age of 56-years-old) as a single dose for Covid-19 immunisation. Medical history included suspected to COVID-19 (unspecified date and duration). Concomitant medication was reported as vitamins (manufacturer unknown) which were taken within two weeks of vaccination. Patient showed reaction to prednisone and was allergic to shellfish and nuts. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021, in morning patient experienced headache and was not able to get up from the bed. On 17Mar2021 patient experienced diarrhoea and the headache was continuing. Patient also experienced upset stomach and pain in left arm. She also has experienced a bump at injection site. Patient did not receive any therapeutic measures for the events. The clinical outcome of headache was reported to be recovering at the time of report. the clinical outcome of the events diarrhoea, upset stomach, pain in left arm and bump at injection site were unknown. It was unknown if the patient had tested positive for COVID-19 since having the vaccine.    No further information is expected. Information about lot number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Aches; This is a spontaneous report from a contactable Consumer, the patient. A 64 years old non-pregnant female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID 19 mRNA Vaccine; Lot numb: EN6208) via unspecified route of administration on left arm on 16Mar2021 at 11:00(at the age of 64 years old) as a single dose for COVID 19 immunisation. Medical history included Bronchiectasis. Concomitant drugs included and taken before two weeks of vaccinations which includes ADVAIR (Fluticasone Propionate/ Salmeterol), PRILOSEC (Omeprazole), XYZAL (Levocetrizine), Azithromycin, Losartan for unknown indication. Allergies to medications, food, or other products was reported for the drug Sulfa. Prior to vaccination, the patient had not been tested positive for COVID 19. On 17Mar2021 at 15:00 the experienced the events fever, chills and aches. Since the vaccination, the patient had not been tested positive for COVID-19. The clinical outcome of the events fever, chills and aches was recovered on unknown date. No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Nausea, Vertigo
Clinical narrative: Severe dizziness; vertigo; Loss of balance; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 67-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no: EN6208), via an unspecified route of administration in the right arm on 17Mar2021 at 12:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included Asthma, allergies, high blood pressure and coronary artery disease on unknown dates. The patient was allergic to codeine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not tested for COVID-19. Concomitant medication included BRILINTA, SINGULAR, AZELASTINE from unknown dates for unknown indication and unknown medication for high blood pressure. The patient experienced severe dizziness, vertigo, off balance and nausea on 17Mar2021 at 22:00. Therapeutic measures were not taken for the reported events. The clinical outcome of the events dizziness, vertigo, off balance and nausea was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: Severe body aches; Tiredness; Sore arm; Fever; This is a spontaneous report received from a non-contactable consumer. A 58-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 58-years-old), as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient was allergic to sulfa antibiotics (MANUFACTURER UNKNOWN), trimethoprim (MANUFACTURER UNKNOWN), meperidine (MANUFACTURER UNKNOWN), penicillin (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN). Concomitant medications were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 16:00, the patient experienced tiredness, sore arm, fever and severe body aches. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the adverse events tiredness, sore arm, fever and severe body aches. The clinical outcome of the events tiredness, sore arm, fever and severe body aches was recovering.   No follow-up attempts are needed. No further information is expected.